REVIEW
Published on 17 Mar 2026
Review of advances in CAR-T therapies in malignant hematology
doi 10.3389/fonc.2026.1768614
- 1,456 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
3,166
Total downloads
28k
Total views and downloads
Articles
CASE REPORT
Published on 12 Mar 2026
Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton’s tyrosine kinase inhibitor and bispecific antibody therapy
doi 10.3389/fonc.2026.1738551
- 1,390 views
- 1 citation
CASE REPORT
Published on 26 Feb 2026
Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson’s disease—unfolding clinical challenges
doi 10.3389/fonc.2026.1759390
- 1,692 views
- 1 citation
CASE REPORT
Published on 05 Jan 2026
Case Report: autologous stem cell boost enables hematopoietic recovery after severe cytopenia induced by BCMA-targeted bispecific antibody therapy in multiple myeloma
doi 10.3389/fonc.2025.1705843
- 2,075 views
METHODS
Published on 19 Nov 2025
Proposed observational study protocol for early differentiation of cytokine release syndrome and sepsis in CAR-T recipients with haematological malignancies using the IL-6/PCT ratio: the DRACARYS study
doi 10.3389/fonc.2025.1683350
- 2,393 views
CASE REPORT
Published on 29 Oct 2025
Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma
doi 10.3389/fimmu.2025.1697566
- 2,053 views
- 1 citation
ORIGINAL RESEARCH
Published on 27 Oct 2025
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease
doi 10.3389/fonc.2025.1663814
- 3,386 views
- 4 citations
SYSTEMATIC REVIEW
Published on 29 Sep 2025
CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis
doi 10.3389/fimmu.2025.1611984
- 7,353 views
- 1 citation
CASE REPORT
Published on 18 Sep 2025
Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory amyloidosis: a case study
doi 10.3389/fonc.2025.1664171
- 2,328 views
- 1 citation
